-
1
-
-
0003146557
-
On the removal of diffusible substances from the circulating blood by dialysis
-
Abel JJ, Rowntree LG, Turner BB. On the removal of diffusible substances from the circulating blood by dialysis. Trans Assoc Am Physicians 1913; 58:51-54.
-
(1913)
Trans Assoc Am Physicians
, vol.58
, pp. 51-54
-
-
Abel, J.J.1
Rowntree, L.G.2
Turner, B.B.3
-
2
-
-
84861090766
-
The application of hemodialysis to the treatment of barbiturate poisoning
-
Epub 1953/04/01
-
Kyle LH, Jeghers H, Walsh WP, Doolan PD, Wishinsky H, Pallotta A. The application of hemodialysis to the treatment of barbiturate poisoning. J Clin Invest 1953; 32:364-371. Epub 1953/04/01.
-
(1953)
J Clin Invest
, vol.32
, pp. 364-371
-
-
Kyle, L.H.1
Jeghers, H.2
Walsh, W.P.3
Doolan, P.D.4
Wishinsky, H.5
Pallotta, A.6
-
3
-
-
0001186322
-
The role of hemodialysis (artificial kidney) in acute poisoning
-
Schreiner GE. The role of hemodialysis (artificial kidney) in acute poisoning. AMA Arch Intern Med 1958; 102:896-913.
-
(1958)
AMA Arch Intern Med
, vol.102
, pp. 896-913
-
-
Schreiner, G.E.1
-
5
-
-
0033769485
-
Comparison of patients hemodialyzed for lithium poisoning and those for whom dialysis was recommended by PCC but not done: What lesson can we learn?
-
Epub 2000/12/06
-
Bailey B, McGuigan M. Comparison of patients hemodialyzed for lithium poisoning and those for whom dialysis was recommended by PCC but not done: what lesson can we learn? Clin Nephrol 2000; 54:388-392. Epub 2000/12/06.
-
(2000)
Clin Nephrol
, vol.54
, pp. 388-392
-
-
Bailey, B.1
McGuigan, M.2
-
6
-
-
3042651139
-
Grading quality of evidence and strength of recommendations
-
Epub 2004/06/19
-
Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. Grading quality of evidence and strength of recommendations. BMJ 2004;328:1490. Epub 2004/06/19.
-
(2004)
BMJ
, vol.328
, pp. 1490
-
-
Atkins, D.1
Best, D.2
Briss, P.A.3
Eccles, M.4
Falck-Ytter, Y.5
Flottorp, S.6
-
7
-
-
80053067126
-
WHO guidelines for the programmatic management of drugresistant tuberculosis: 2011 update
-
Epub 2011/08/11
-
Falzon D, Jaramillo E, Schunemann HJ, Arentz M, Bauer M, Bayona J, et al. WHO guidelines for the programmatic management of drugresistant tuberculosis: 2011 update. Eur Respir J 2011; 38:516-528. Epub 2011/08/11.
-
(2011)
Eur Respir J
, vol.38
, pp. 516-528
-
-
Falzon, D.1
Jaramillo, E.2
Schunemann, H.J.3
Arentz, M.4
Bauer, M.5
Bayona, J.6
-
8
-
-
33745843618
-
-
Appraisal of Guidelines for Research & Evaluation London: The AGREE Collaboration
-
Appraisal of Guidelines for Research & Evaluation. AGREE Instrument. London: The AGREE Collaboration; 2001.
-
(2001)
AGREE Instrument
-
-
-
9
-
-
42149088537
-
Principles and techniques applied to enhance elimination
-
In: Nelson LS LN, Howland MA, et al, editor. 9th ed. New York, NY: McGraw Hill
-
Goldfarb DS. Principles and techniques applied to enhance elimination. In: Nelson LS LN, Howland MA, et al, editor. Goldfrank ' s Toxicologic Emergencies, 9th ed. New York, NY: McGraw Hill; 2011: 142.
-
(2011)
Goldfrank ' s Toxicologic Emergencies
, pp. 142
-
-
Goldfarb, D.S.1
-
10
-
-
0036368787
-
American academy of clinical toxicology practice guidelines on the treatment of methanol poisoning
-
Epub 2002/09/10
-
Barceloux DG, Bond GR, Krenzelok EP, Cooper H, Vale JA. American academy of clinical toxicology practice guidelines on the treatment of methanol poisoning. J Toxicol Clin Toxicol 2002; 40:415-446. Epub 2002/09/10.
-
(2002)
J Toxicol Clin Toxicol
, vol.40
, pp. 415-446
-
-
Barceloux, D.G.1
Bond, G.R.2
Krenzelok, E.P.3
Cooper, H.4
Vale, J.A.5
-
11
-
-
0345151833
-
American academy of clinical toxicology practice guidelines on the treatment of ethylene glycol poisoning. Ad Hoc Committee
-
Epub 1999/09/25
-
Barceloux DG, Krenzelok EP, Olson K, Watson W. American academy of clinical toxicology practice guidelines on the treatment of ethylene glycol poisoning. Ad Hoc Committee. J Toxicol Clin Toxicol 1999;3 7:537-560. Epub 1999/09/25.
-
(1999)
J Toxicol Clin Toxicol
, vol.3
, Issue.7
, pp. 537-560
-
-
Barceloux, D.G.1
Krenzelok, E.P.2
Olson, K.3
Watson, W.4
-
12
-
-
0036270809
-
An evidence based fl owchart to guide the management of acute salicylate (aspirin) overdose
-
Epub 2002/04/25
-
Dargan PI, Wallace CI, Jones AL. An evidence based fl owchart to guide the management of acute salicylate (aspirin) overdose. Emerg Med J 2002; 19:206-209. Epub 2002/04/25.
-
(2002)
Emerg Med J
, vol.19
, pp. 206-209
-
-
Dargan, P.I.1
Wallace, C.I.2
Jones, A.L.3
-
13
-
-
43249093669
-
What is "quality of evidence" and why is it important to clinicians?
-
Epub 2008/05/06
-
Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schunemann HJ. What is "quality of evidence" and why is it important to clinicians? BMJ 2008; 336:995-998. Epub 2008/05/06.
-
(2008)
BMJ
, vol.336
, pp. 995-998
-
-
Guyatt, G.H.1
Oxman, A.D.2
Kunz, R.3
Vist, G.E.4
Falck-Ytter, Y.5
Schunemann, H.J.6
-
14
-
-
55249103596
-
Use of hemodialysis and hemoperfusion in poisoned patients
-
Epub 2008/09/19
-
Holubek WJ, Hoffman RS, Goldfarb DS, Nelson LS. Use of hemodialysis and hemoperfusion in poisoned patients. Kidney Int 2008; 74:1327-1334. Epub 2008/09/19.
-
(2008)
Kidney Int
, vol.74
, pp. 1327-1334
-
-
Holubek, W.J.1
Hoffman, R.S.2
Goldfarb, D.S.3
Nelson, L.S.4
-
15
-
-
84861029789
-
-
internal data derived from American Association of Poison Control Centers' National Poison Data System (NPDS)
-
Holubek WJ. (internal data derived from American Association of Poison Control Centers' National Poison Data System (NPDS)). 2011.
-
(2011)
-
-
Holubek, W.J.1
-
16
-
-
69449100622
-
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
-
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ. 2009;339:b2535.
-
(2009)
BMJ.
, vol.339
-
-
Moher, D.1
Liberati, A.2
Tetzlaff, J.3
Altman, D.G.4
-
17
-
-
0002239144
-
Consensus development methods, and their use in clinical guideline development
-
Epub 1998/04/30
-
Murphy MK, Black NA, Lamping DL, McKee CM, Sanderson CF, Askham J, et al. Consensus development methods, and their use in clinical guideline development. Health technology assessment 1998;2:i-iv, 1-88. Epub 1998/04/30.
-
(1998)
Health technology assessment
, vol.2
, Issue.1-4
, pp. 1-88
-
-
Murphy, M.K.1
Black, N.A.2
Lamping, D.L.3
McKee, C.M.4
Sanderson, C.F.5
Askham, J.6
-
18
-
-
0003423053
-
-
Santa Monica CA, Available from
-
Fitch K, Bernstein SJ, Aguilar MD, Burnand B, LaCalle JR, Lazaro P, et al. The RAND/UCLA Appropriateness Method User's Manual. Santa Monica, CA2011. Available from: Http://www.rand.org/.
-
(2011)
The RAND/UCLA Appropriateness Method User's Manual
-
-
Fitch, K.1
Bernstein, S.J.2
Aguilar, M.D.3
Burnand, B.4
LaCalle, J.R.5
Lazaro, P.6
|